Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LQDA · against 280 other Healthcare companies of similar size
Ranked #128 of 281 · scores higher than 54% of peers
Bars: peers in each 10-point band of the valuation score34 peers with a valuation score of 50–59, including LQDA · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | LQDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 277 reported | 3.3% | 2.5% | 58% | 30% | |
| EBITDA yieldHigher is better · 276 reported | 4.6% | 4.8% | 49% | 50% | |
| Free cash flow yieldHigher is better · 147 reported | 3.9% | 0.9% | 69% | 20% | |
| Book yieldHigher is better · 275 reported | 5.2% | 28.3% | 8% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 5 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 125 | 32.3B CNY (≈$4.5B) | 60 | 55 | |
| 125 | 23.2B CNY (≈$3.2B) | 60 | 62 | |
| 125 | 5.0B USD | 60 | 60 | |
| 128 | 4.3B USD | 59 | 54 | |
| 128 | 3.8B USD | 59 | 71 | |
| 128 | 5.3B USD | 59 | 63 | |
| 131 | 19.0B CNY (≈$2.7B) | 58 | 55 | |
| 131 | 35.1B CNY (≈$4.9B) | 58 | 56 | |
| 131 | 24.7B CNY (≈$3.5B) | 58 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score